In the APP23/PS45 double-transgenic mouse model of AD, the administration of L-lactate increased the level of APP lactylation modification, resulting in lower Aβ generation and deposition, as well as alleviated deficits in hippocampal CA1 LTP and cognition (Figure 8). This evidence concerns the gene APP and Alzheimer disease.